NGL Fine Chem Q4 FY26 Results: PAT Rs 13 Cr

NGL Fine Chem Q4 FY26 results were declared on May 21, 2026. The company reported PAT of Rs 13 crore for the quarter ended March 31, 2026, up 1200.0% YoY compared to Rs 1 crore in Q4 FY25. Revenue from operations stood at Rs 149 crore, up 56.0% YoY. Results are on a Consolidated basis. NGL Fine Chem is a Fine Chemicals company listed on Indian stock exchanges.

Click Here – Get Free Investment Predictions

NGL Fine Chem Q4 FY26 Financial Highlights

Metric	Q4 FY26 (Rs Cr)	Q4 FY25 (Rs Cr)	YoY Change
Revenue	149	95	+56.0%
Gross Profit	Rs 16 crore	3	+433.0%
Net Profit	13	1	+1200.0%
Basis	Consolidated

Note: NGL Fine Chem Q4 FY26 results declared May 21, 2026. Verify from BSE/NSE audited filings before investment decisions.

NGL Fine Chem Q4 FY26 Performance Analysis

The NGL Fine Chem Q4 FY26 results reflect the company’s operational performance in the January to March 2026 quarter. Strong PAT growth of 1,200% YoY to Rs 13 crore demonstrates significant earnings improvement. NGL Fine Chem operates in the Fine Chemicals sector, which benefited from India’s GDP growth above 6.5% in FY26.

Revenue grew 56% YoY to Rs 149 crore, driven by strong demand and business expansion.

Screen the best stocks on the Univest Screener.

Key Factors Driving NGL Fine Chem Q4 FY26 Results

Revenue and Business Performance

NGL Fine Chem Q4 FY26 revenue of Rs 149 crore was up 56.0% YoY. The strong revenue growth reflects market share gains, capacity expansion, and healthy demand conditions.

Profitability and Margins

the business PAT of Rs 13 crore up 1200.0% YoY. The strong PAT growth demonstrates improving operational leverage and cost discipline.

India Macro Backdrop

The January to March 2026 quarter benefited from India’s GDP growth above 6.5%, government capital expenditure of Rs 11.21 lakh crore for FY27, and resilient domestic consumption. RBI’s accommodative stance supported credit and demand conditions. The Fine Chemicals sector saw strong tailwinds during this period.

FY27 Outlook

Following the firm results, management commentary on FY27 revenue guidance, margin expansion roadmap, and capital allocation will be key investor watchpoints. The Fine Chemicals sector continues to benefit from India’s long-term structural growth.

Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.

Frequently Asked Questions on the company

Investments in securities are subject to market risk. This content is for educational purposes only. Verify all figures from BSE/NSE filings. Consult a SEBI-registered financial advisor.